Insulin Glulisine


- TRADE NAME: Apidra (Sanofi-Aventis)
- INDICATIONS: Diabetes
- CLASS: Insulin analog
- HALF-LIFE: 13–42 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Albuterol, Alcohol, Anitpsychotics, Beta blockers, Clonidine, Clozapine, Corticosteroids, Danazol, Disopyramide, Diuretics, Epinephrine, Fibrates, Fluoxetine, Glucagon, Guanethidine, Isoniazid, Lithium, MAO inhibitors, Niacin, Oral antidiabetic agents, Oral Contraceptives, Pentamidine, Pentoxifylline, Phenothiazine derivatives, Pramlintide, Propoxyphene, Propranolol, Protease inhibitors, Reserpine, Salicylates, Somatostatin analogs, Somatropin, Sulfonamide antibiotics, Terbutaline, Thyroid hormones
PREGNANCY CATEGORY: C
Various forms of insulin are available - see other insulin profiles for reaction details.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric